TRPC5 and kidney disorder: These data, which await validation in other models of progressive proteinuric kidney disease, emphasize the central role of TRPC5 in primary podocytopathies and raise hope that targeting TRPC5 may indeed ultimately offer a novel treatment option for glomerular diseases caused by the disruption of the podocyte cytoskeleton.